The following tables present selected financial data from 2012 and 2011.
Years Ended December 31, |
|||||||
(in thousands, except per share amounts) |
2012 |
2011 |
|||||
Net income to shareholders |
$ |
253,385 |
$ |
142,026 |
|||
Comprehensive income to shareholders |
$ |
503,802 |
$ |
251,853 |
|||
Weighted average diluted shares |
9,666 |
9,726 |
|||||
Diluted net income per share |
$ |
25.89 |
$ |
14.60 |
|||
(in thousands, except per share amounts) |
December 31, 2012 |
December 31, 2011 |
|||||
Book value per common share outstanding |
$ |
403.85 |
$ |
352.10 |
|||
Common shares outstanding |
9,629 |
9,621 |
The increase in diluted net income per share during 2012 was primarily due to improved underwriting results, which were driven by lower losses related to natural catastrophes, more favorable development of prior years' loss reserves and lower attritional losses.
Comprehensive income to shareholders for 2012 was
Combined Ratio Analysis |
|||
Years Ended December 31, |
|||
2012 |
2011 |
||
Excess and Surplus Lines |
94% |
86% |
|
Specialty Admitted |
108% |
109% |
|
London Insurance Market |
89% |
116% |
|
Consolidated |
97% |
102% |
The decrease in the consolidated combined ratio was due to a lower current accident year loss ratio and more favorable development of prior years' loss reserves, partially offset by a higher expense ratio compared to 2011. The 2012 combined ratio included
The Excess and Surplus Lines segment's combined ratio for 2012 was 94% (including five points of underwriting loss related to Hurricane Sandy) compared to 86% (including three points of underwriting loss related to natural catastrophes) in 2011. The increase in the 2012 combined ratio was primarily due to less favorable development of prior years' loss reserves compared to 2011. The Excess and Surplus Lines segment's 2012 combined ratio included
The Specialty Admitted segment's combined ratio for 2012 was 108% (including three points of underwriting loss related to Hurricane Sandy) compared to 109% (including two points of underwriting loss related to natural catastrophes) in 2011. In 2012, more favorable development of prior years' loss reserves and a lower current accident year loss ratio were offset by a higher expense ratio compared to 2011. The Specialty Admitted segment's 2012 combined ratio included
The London Insurance Market segment's combined ratio for 2012 was 89% (including six points of underwriting loss related to Hurricane Sandy) compared to 116% (including 18 points of underwriting loss related to natural catastrophes) in 2011. Excluding the impact of natural catastrophes in both periods, the combined ratio decreased in 2012 due to more favorable development of prior years' loss reserves and lower attritional losses on the current accident year, primarily on our property lines within the Specialty division. The London Insurance Market segment's 2012 combined ratio included
Premium Analysis |
|||||||||||||||
Years Ended December 31, |
|||||||||||||||
Gross Written Premiums |
Earned Premiums |
||||||||||||||
(dollars in thousands) |
2012 |
2011 |
2012 |
2011 |
|||||||||||
Excess and Surplus Lines |
$ |
956,273 |
$ |
893,427 |
$ |
793,159 |
$ |
756,306 |
|||||||
Specialty Admitted |
669,692 |
572,392 |
588,758 |
527,293 |
|||||||||||
London Insurance Market |
887,720 |
825,301 |
765,216 |
695,753 |
|||||||||||
Other Insurance (Discontinued Lines) |
(4) |
131 |
(5) |
(12) |
|||||||||||
Total |
$ |
2,513,681 |
$ |
2,291,251 |
$ |
2,147,128 |
$ |
1,979,340 |
Gross written premiums for 2012 increased 10% compared to 2011. The increase in gross premium volume was attributable to higher gross premium volume in each of our three operating segments. In 2012, the Specialty Admitted segment included
During the latter part of 2011, we saw price declines stabilize and achieved modest price increases in several lines, most notably the marine and energy products within the London Insurance Market segment. During 2012, we have generally seen mid-single digit favorable rate changes compared to flat to small single digit rate declines in 2011. We routinely review the pricing of our major product lines and will continue to pursue price increases for most product lines in 2013; however, when we believe the prevailing market price will not support our underwriting profit targets, the business is not written. As a result of our underwriting discipline, gross premium volume may vary when we alter our product offerings to maintain or improve underwriting profitability.
Net retention of gross premium volume was 88% for 2012 and 89% for 2011. As part of our underwriting philosophy, we seek to offer products with limits that do not require significant amounts of reinsurance. We purchase reinsurance in order to reduce our retention on individual risks and enable us to write policies with sufficient limits to meet policyholder needs.
Earned premiums for 2012 increased 8% compared to 2011. In 2012, the Specialty Admitted segment included
Net investment income for 2012 was
Net realized investment gains for 2012 were
Other revenues and other expenses include the results of our non-insurance operations, which we refer to collectively as
In
Invested assets were
Interest expense for 2012 was
Income tax expense for 2012 was 17% of our income before income taxes compared to 22% in 2011. In both periods, the effective tax rate differs from the statutory tax rate of 35% primarily as a result of tax-exempt investment income. Additionally, in 2012, we had higher earnings from our foreign operations, which are taxed at a lower rate.
In
FORWARD-LOOKING STATEMENTS
This release includes statements about future economic performance, finances, expectations, plans and prospects of Alterra and
This release contains certain forward-looking statements within the meaning of the U.S. federal securities laws. Statements that are not historical facts, including statements about Alterra's and
Risks and uncertainties relating to the proposed transaction include the risks that: (1) the parties will not obtain the requisite shareholder or regulatory approvals for the transaction; (2) the anticipated benefits of the transaction will not be realized or the parties may experience difficulties in successfully integrating the two companies; (3) the parties may not be able to retain key personnel; (4) the conditions to the closing of the proposed merger may not be satisfied or waived; (5) the outcome of any legal proceedings to the extent initiated against Alterra or
ADDITIONAL INFORMATION ABOUT THE PROPOSED MERGER AND WHERE TO FIND IT
This release relates to a proposed merger between Alterra and Markel. On
PARTICIPANTS IN THE SOLICITATION
Alterra and
CONFERENCE CALL
Our previously announced conference call, which will involve discussion of our financial results and business developments and may include forward-looking information, will be held
Markel Corporation and Subsidiaries |
|||||||||||||||
Consolidated Statements of Income and Comprehensive Income |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands, except per share data) |
2012 |
2011 |
2012 |
2011 |
|||||||||||
OPERATING REVENUES |
|||||||||||||||
Earned premiums |
$ |
573,939 |
$ |
516,825 |
$ |
2,147,128 |
$ |
1,979,340 |
|||||||
Net investment income |
74,273 |
67,125 |
282,107 |
263,676 |
|||||||||||
Net realized investment gains: |
|||||||||||||||
Other-than-temporary impairment losses |
(7,927) |
(2,697) |
(12,078) |
(14,250) |
|||||||||||
Other-than-temporary impairment losses recognized in other comprehensive income |
— |
(2,640) |
— |
(5,946) |
|||||||||||
Other-than-temporary impairment losses recognized in net income |
(7,927) |
(5,337) |
(12,078) |
(20,196) |
|||||||||||
Net realized investment gains, excluding other-than-temporary impairment losses |
14,164 |
15,771 |
43,671 |
56,053 |
|||||||||||
Net realized investment gains |
6,237 |
10,434 |
31,593 |
35,857 |
|||||||||||
Other revenues |
153,506 |
90,716 |
539,284 |
351,077 |
|||||||||||
Total Operating Revenues |
807,955 |
685,100 |
3,000,112 |
2,629,950 |
|||||||||||
OPERATING EXPENSES |
|||||||||||||||
Losses and loss adjustment expenses |
340,994 |
282,343 |
1,154,068 |
1,209,986 |
|||||||||||
Underwriting, acquisition and insurance expenses |
234,150 |
208,668 |
929,472 |
810,179 |
|||||||||||
Amortization of intangible assets |
8,434 |
6,705 |
33,512 |
24,291 |
|||||||||||
Other expenses |
134,786 |
90,776 |
478,248 |
309,046 |
|||||||||||
Total Operating Expenses |
718,364 |
588,492 |
2,595,300 |
2,353,502 |
|||||||||||
Operating Income |
89,591 |
96,608 |
404,812 |
276,448 |
|||||||||||
Interest expense |
23,694 |
21,736 |
92,762 |
86,252 |
|||||||||||
Income Before Income Taxes |
65,897 |
74,872 |
312,050 |
190,196 |
|||||||||||
Income tax expense |
7,804 |
22,565 |
53,802 |
41,710 |
|||||||||||
Net Income |
$ |
58,093 |
$ |
52,307 |
$ |
258,248 |
$ |
148,486 |
|||||||
Net income attributable to noncontrolling interests |
1,301 |
2,131 |
4,863 |
6,460 |
|||||||||||
Net Income to Shareholders |
$ |
56,792 |
$ |
50,176 |
$ |
253,385 |
$ |
142,026 |
|||||||
OTHER COMPREHENSIVE INCOME |
|||||||||||||||
Change in net unrealized gains on investments, net of taxes: |
|||||||||||||||
Net holding gains arising during the period |
$ |
20,369 |
$ |
147,445 |
$ |
266,425 |
$ |
141,839 |
|||||||
Unrealized other-than-temporary impairment losses on fixed maturities arising during the period |
(24) |
2,286 |
(160) |
3,943 |
|||||||||||
Reclassification adjustments for net gains included in net income |
(3,897) |
(7,055) |
(24,051) |
(22,341) |
|||||||||||
Change in net unrealized gains on investments, net of taxes |
16,448 |
142,676 |
242,214 |
123,441 |
|||||||||||
Change in foreign currency translation adjustments, net of taxes |
(1,393) |
1,347 |
1,534 |
(4,191) |
|||||||||||
Change in net actuarial pension loss, net of taxes |
5,177 |
(10,539) |
6,664 |
(9,459) |
|||||||||||
Total Other Comprehensive Income |
20,232 |
133,484 |
250,412 |
109,791 |
|||||||||||
Comprehensive Income |
$ |
78,325 |
$ |
185,791 |
$ |
508,660 |
$ |
258,277 |
|||||||
Comprehensive income attributable to noncontrolling interests |
1,338 |
2,095 |
4,858 |
6,424 |
|||||||||||
Comprehensive Income to Shareholders |
$ |
76,987 |
$ |
183,696 |
$ |
503,802 |
$ |
251,853 |
|||||||
NET INCOME PER SHARE |
|||||||||||||||
Basic |
$ |
6.25 |
$ |
5.21 |
$ |
25.96 |
$ |
14.66 |
|||||||
Diluted |
$ |
6.23 |
$ |
5.19 |
$ |
25.89 |
$ |
14.60 |
|||||||
Selected Data |
December 31, |
||||||||||||||
(dollars and shares in thousands, except per share data) |
2012 |
2011 |
|||||||||||||
Total investments and cash and cash equivalents |
$ |
9,332,745 |
$ |
8,728,147 |
|||||||||||
Reinsurance recoverable on paid and unpaid losses |
829,919 |
829,310 |
|||||||||||||
Goodwill and intangible assets |
1,049,225 |
867,558 |
|||||||||||||
Total assets |
12,556,588 |
11,532,103 |
|||||||||||||
Unpaid losses and loss adjustment expenses |
5,371,426 |
5,398,869 |
|||||||||||||
Unearned premiums |
1,000,261 |
915,930 |
|||||||||||||
Senior long-term debt and other debt |
1,492,550 |
1,293,520 |
|||||||||||||
Total shareholders' equity |
3,888,657 |
3,387,513 |
|||||||||||||
Book value per common share outstanding |
$ |
403.85 |
$ |
352.10 |
|||||||||||
Common shares outstanding |
9,629 |
9,621 |
Markel Corporation and Subsidiaries |
||||||||||||||
Segment Reporting Disclosures |
||||||||||||||
For the Quarters and Years Ended December 31, 2012 and 2011 |
||||||||||||||
Segment Gross Written Premiums |
||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
|||||||||||||
2012 |
2011 |
(dollars in thousands) |
2012 |
2011 |
||||||||||
$ |
250,424 |
$ |
229,438 |
Excess and Surplus Lines |
$ |
956,273 |
$ |
893,427 |
||||||
173,673 |
140,788 |
Specialty Admitted |
669,692 |
572,392 |
||||||||||
183,209 |
148,408 |
London Insurance Market |
887,720 |
825,301 |
||||||||||
2 |
6 |
Other Insurance (Discontinued Lines) |
(4) |
131 |
||||||||||
$ |
607,308 |
$ |
518,640 |
Consolidated |
$ |
2,513,681 |
$ |
2,291,251 |
||||||
Segment Net Written Premiums |
||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
|||||||||||||
2012 |
2011 |
(dollars in thousands) |
2012 |
2011 |
||||||||||
$ |
213,859 |
$ |
202,036 |
Excess and Surplus Lines |
$ |
811,601 |
$ |
772,279 |
||||||
160,425 |
132,513 |
Specialty Admitted |
628,147 |
543,213 |
||||||||||
152,436 |
132,919 |
London Insurance Market |
774,383 |
726,359 |
||||||||||
2 |
(8) |
Other Insurance (Discontinued Lines) |
(5) |
(13) |
||||||||||
$ |
526,722 |
$ |
467,460 |
Consolidated |
$ |
2,214,126 |
$ |
2,041,838 |
||||||
Segment Revenues |
||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
|||||||||||||
2012 |
2011 |
(dollars in thousands) |
2012 |
2011 |
||||||||||
$ |
208,635 |
$ |
198,348 |
Excess and Surplus Lines |
$ |
793,159 |
$ |
756,306 |
||||||
166,482 |
138,593 |
Specialty Admitted |
633,726 |
560,838 |
||||||||||
207,934 |
181,806 |
London Insurance Market |
770,180 |
695,753 |
||||||||||
80,510 |
77,559 |
Investing |
313,700 |
299,533 |
||||||||||
2 |
1 |
Other Insurance (Discontinued Lines) |
(5) |
(12) |
||||||||||
$ |
663,563 |
$ |
596,307 |
Consolidated |
$ |
2,510,760 |
$ |
2,312,418 |
||||||
Reconciliation of Segment Profit (Loss) to Consolidated Operating Income |
||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
|||||||||||||
2012 |
2011 |
(dollars in thousands) |
2012 |
2011 |
||||||||||
$ |
(4,765) |
$ |
44,625 |
Excess and Surplus Lines |
$ |
50,141 |
$ |
109,035 |
||||||
(9,011) |
(13,723) |
Specialty Admitted |
(43,293) |
(45,268) |
||||||||||
15,362 |
(11,693) |
London Insurance Market |
82,663 |
(109,475) |
||||||||||
80,510 |
77,559 |
Investing |
313,700 |
299,533 |
||||||||||
(1,063) |
2,180 |
Other Insurance (Discontinued Lines) |
(21,283) |
4,706 |
||||||||||
144,392 |
88,793 |
Other Revenues (Non-Insurance) |
489,352 |
317,532 |
||||||||||
(127,400) |
(84,428) |
Other Expenses (Non-Insurance) |
(432,956) |
(275,324) |
||||||||||
(8,434) |
(6,705) |
Amortization of Intangible Assets |
(33,512) |
(24,291) |
||||||||||
$ |
89,591 |
$ |
96,608 |
Consolidated |
$ |
404,812 |
$ |
276,448 |
||||||
Segment Combined Ratios |
||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
|||||||||||||
2012 |
2011 |
(dollars in thousands) |
2012 |
2011 |
||||||||||
102 |
% |
78 |
% |
Excess and Surplus Lines |
94 |
% |
86 |
% |
||||||
107 |
% |
107 |
% |
Specialty Admitted |
108 |
% |
109 |
% |
||||||
92 |
% |
106 |
% |
London Insurance Market |
89 |
% |
116 |
% |
||||||
100 |
% |
95 |
% |
Consolidated |
97 |
% |
102 |
% |
Reconciliation of Non-GAAP Financial Measure
The following table reconciles earnings before interest, income taxes, depreciation and amortization (EBITDA) of
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2012 |
2011 |
2012 |
2011 |
|||||||||||
Markel Ventures EBITDA |
$ |
18,980 |
$ |
3,117 |
$ |
60,361 |
$ |
37,325 |
|||||||
Interest expense |
(2,233) |
(2,722) |
(9,782) |
(10,871) |
|||||||||||
Income tax benefit (expense) |
(3,036) |
2,815 |
(7,868) |
(4,335) |
|||||||||||
Depreciation expense |
(4,738) |
(1,708)
|
(14,205) |
(5,106)
|
|||||||||||
Amortization of intangible assets |
(4,076) |
(2,695) |
(15,031) |
(9,267) |
|||||||||||
Markel Ventures net income (loss) |
4,897 |
(1,193) |
13,475 |
7,746 |
|||||||||||
Net income from other Markel operations |
51,895 |
51,369 |
239,910 |
134,280 |
|||||||||||
Net income to shareholders |
$ |
56,792 |
$ |
50,176 |
$ |
253,385 |
$ |
142,026 |
Interest expense for the quarters ended
Markel Ventures EBITDA is a non-GAAP financial measure and is reconciled to consolidated net income to shareholders in the above table. Markel Ventures EBITDA reflects income attributable to our ownership interest in
SOURCE
Bruce Kay, Markel Corporation, +1-804-747-0136, bkay@markelcorp.com